These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21872966)

  • 1. Binding sites in membrane proteins--diversity, druggability and prospects.
    Adams R; Worth CL; Guenther S; Dunkel M; Lehmann R; Preissner R
    Eur J Cell Biol; 2012 Apr; 91(4):326-39. PubMed ID: 21872966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemogenomics in drug discovery: computational methods based on the comparison of binding sites.
    Vulpetti A; Kalliokoski T; Milletti F
    Future Med Chem; 2012 Oct; 4(15):1971-9. PubMed ID: 23088277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting protein druggability.
    Hajduk PJ; Huth JR; Tse C
    Drug Discov Today; 2005 Dec; 10(23-24):1675-82. PubMed ID: 16376828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based computational analysis of protein binding sites for function and druggability prediction.
    Nisius B; Sha F; Gohlke H
    J Biotechnol; 2012 Jun; 159(3):123-34. PubMed ID: 22197384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alignment-independent comparison of binding sites based on DrugScore potential fields encoded by 3D Zernike descriptors.
    Nisius B; Gohlke H
    J Chem Inf Model; 2012 Sep; 52(9):2339-47. PubMed ID: 22881363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized modeling of enzyme-ligand interactions using proteochemometrics and local protein substructures.
    Strömbergsson H; Kryshtafovych A; Prusis P; Fidelis K; Wikberg JE; Komorowski J; Hvidsten TR
    Proteins; 2006 Nov; 65(3):568-79. PubMed ID: 16948162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational approaches to identifying and characterizing protein binding sites for ligand design.
    Henrich S; Salo-Ahen OM; Huang B; Rippmann FF; Cruciani G; Wade RC
    J Mol Recognit; 2010; 23(2):209-19. PubMed ID: 19746440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rank information: a structure-independent measure of evolutionary trace quality that improves identification of protein functional sites.
    Yao H; Mihalek I; Lichtarge O
    Proteins; 2006 Oct; 65(1):111-23. PubMed ID: 16894615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the multi-modal binding propensity of small molecules: towards an understanding of drug promiscuity.
    Park K; Lee S; Ahn HS; Kim D
    Mol Biosyst; 2009 Aug; 5(8):844-53. PubMed ID: 19603120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docking and scoring in virtual screening for drug discovery: methods and applications.
    Kitchen DB; Decornez H; Furr JR; Bajorath J
    Nat Rev Drug Discov; 2004 Nov; 3(11):935-49. PubMed ID: 15520816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of deleterious functional effects of amino acid mutations using a library of structure-based function descriptors.
    Herrgard S; Cammer SA; Hoffman BT; Knutson S; Gallina M; Speir JA; Fetrow JS; Baxter SM
    Proteins; 2003 Dec; 53(4):806-16. PubMed ID: 14635123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to local similarity of protein binding sites substantially improves computational drug design results.
    Ramensky V; Sobol A; Zaitseva N; Rubinov A; Zosimov V
    Proteins; 2007 Nov; 69(2):349-57. PubMed ID: 17623865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive identification of "druggable" protein ligand binding sites.
    An J; Totrov M; Abagyan R
    Genome Inform; 2004; 15(2):31-41. PubMed ID: 15706489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Merging chemical and biological space: Structural mapping of enzyme binding pocket space.
    Weskamp N; Hüllermeier E; Klebe G
    Proteins; 2009 Aug; 76(2):317-30. PubMed ID: 19173307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The family of G protein-coupled receptors: an example of membrane proteins.
    Tikhonova IG; Fourmy D
    Methods Mol Biol; 2010; 654():441-54. PubMed ID: 20665280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and advances in computational docking: 2009 in review.
    Yuriev E; Agostino M; Ramsland PA
    J Mol Recognit; 2011; 24(2):149-64. PubMed ID: 21360606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDB-scale analysis of known and putative ligand-binding sites with structural sketches.
    Ito J; Tabei Y; Shimizu K; Tomii K; Tsuda K
    Proteins; 2012 Mar; 80(3):747-63. PubMed ID: 22113700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for computer-aided chemical biology. Part 1: Design of a benchmark system for the evaluation of compound selectivity.
    Stumpfe D; Ahmed HE; Vogt I; Bajorath J
    Chem Biol Drug Des; 2007 Sep; 70(3):182-94. PubMed ID: 17718713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.